Posts Tagged ‘CCFC and AbbVie Awarding Scholarships to Empower Students Living with IBD’

CCFC and AbbVie Awarding Scholarships to Empower Students Living with IBD

Friday, May 31st, 2013



Crohn’s and Col­i­tis Foun­da­tion of Canada and Abb­Vie Cor­po­ra­tion Award­ing Schol­ar­ships to Empower Seven Incred­i­ble Youth with IBD


Nom­i­na­tions now being accepted for Sec­ond Annual Schol­ar­ship Pro­gram that rewards remark­able stu­dents liv­ing with Crohn’s dis­ease and ulcer­a­tive colitis.

Canada has one of the high­est reported preva­lence of inflam­ma­tory bowel dis­ease (IBD) in the world and 20–30% of peo­ple with IBD are diag­nosed before the age of 20*. To sup­port Cana­dian stu­dents liv­ing with IBD and raise aware­ness about this chronic dis­ease, the Abb­Vie IBD Schol­ar­ship Pro­gram  is accept­ing nom­i­na­tions from young peo­ple liv­ing with IBD.

In part­ner­ship with the Crohn’s and Col­i­tis Foun­da­tion of Canada (CCFC), the Abb­Vie IBD Schol­ar­ship Pro­gram is designed to award stu­dents who are liv­ing well with IBD, and strive to sus­tain an opti­mal level of well­ness allow­ing them to excel while inspir­ing oth­ers to do the same. Through an unre­stricted edu­ca­tional grant by Abb­Vie, CCFC will extend seven (7) one-time schol­ar­ships of up to $5,000 CAN to stu­dents liv­ing with IBD who are enter­ing into or are cur­rently attend­ing a post-secondary edu­ca­tional insti­tu­tion. Stu­dents of all ages are wel­come to apply and the schol­ar­ship can be used for any Cana­dian post-secondary insti­tu­tion.  “I am com­mit­ted to liv­ing each day to the fullest and I’m so grate­ful to the CCFC and Abb­Vie for giv­ing me the oppor­tu­nity and inspi­ra­tion to push harder and help me excel at my aca­d­e­mic goals,” says Clin­ton Shard, one of seven (7) 2012 “gutsy” schol­ar­ship win­ners. “While the mon­e­tary schol­ar­ship pro­vides an incen­tive, it also rep­re­sents an invest­ment in assist­ing stu­dents liv­ing with IBD and help­ing us achieve our dreams.”

Through ini­tia­tives such as the schol­ar­ship pro­gram, Abb­Vie aims to con­tinue accel­er­at­ing the recog­ni­tion of the bur­den of IBD and help fur­ther the global dis­sem­i­na­tion of evolv­ing approaches to bet­ter care for peo­ple liv­ing with IBD.

“Abb­Vie is proud to part­ner again this year with CCFC for the Abb­Vie IBD Schol­ar­ship Pro­gram. This ini­tia­tive is a great exam­ple of a part­ner­ship that makes a dif­fer­ence in people’s lives,” states Felipe Pas­trana, Gen­eral Man­ager of Abb­Vie Canada. “While our name, Abb­Vie, has changed – our com­mit­ment to the IBD com­mu­nity endures. Over the years, Abb­Vie has shown con­tin­ued com­mit­ment to peo­ple liv­ing with IBD by help­ing orga­ni­za­tions and health care providers alike bet­ter under­stand the impact of these dis­eases on people’s lives. Abb­Vie rec­og­nizes the need for bet­ter dis­ease diag­no­sis and mon­i­tor­ing to help improve the lives of mil­lions of peo­ple affected by this chronic and debil­i­tat­ing dis­ease.” IBD Inci­dence Rates on the Rise Inflam­ma­tory bowel dis­ease, or IBD, is a group of dis­or­ders that causes the intestines to become inflamed and ulcer­ated. This is caused by an abnor­mal response of the body’s immune system.

A recent sur­vey con­ducted by the CCFC found that 69 per­cent of peo­ple who had IBD when they were young were delayed in com­plet­ing their post-secondary edu­ca­tion. 89 per­cent who had IBD as a child felt that they could have achieved more at school with­out their dis­ease. Since there is cur­rently no known cure or cause, young peo­ple need strate­gies to achieve their best long-term health despite their diagnosis.

Unfor­tu­nately, a major­ity of peo­ple liv­ing with IBD endure many chal­lenges when it comes to their edu­ca­tion. With inten­sive med­ical treat­ments, debil­i­tat­ing symp­toms and lengthy hos­pi­tal stays, keep­ing up with school can become extremely difficult.

“Due to the iso­lat­ing nature of the dis­ease, peo­ple liv­ing with IBD too often miss out on the great life expe­ri­ences many of us take for granted, includ­ing com­plet­ing their edu­ca­tion,” says Dr. Kevin Glas­gow, CCFC’s Chief Exec­u­tive Offi­cer. “The Abb­Vie IBD Schol­ar­ship was born of the desire to sup­port stu­dents with Crohn’s and col­i­tis and help empower them to con­tinue their edu­ca­tion and excel to their fullest poten­tial. Our chal­lenge is to find more youth like Clin­ton who are speak­ing out to help reduce the stigma asso­ci­ated with diges­tive dis­ease. By telling their sto­ries through the Abb­Vie IBD Schol­ar­ship Pro­gram, we know we can inspire many oth­ers to do the same at a time when advanc­ing pub­lic under­stand­ing of IBD is needed most.”

The Abb­Vie IBD Schol­ar­ship Pro­gram – The A, B, C’s The Abb­Vie IBD Schol­ar­ship Pro­gram, in part­ner­ship with CCFC, is designed for appli­cants of any age enter­ing into or attend­ing a Canadian-based post-secondary insti­tu­tion. Appli­cants must be:

· A legal and per­ma­nent res­i­dent of Canada;

· Diag­nosed with inflam­ma­tory bowel dis­ease by a physician;

· Seek­ing an associate’s, under­grad­u­ate, or grad­u­ate degree from a Cana­dian uni­ver­sity; col­lege; or enrolled in a trade school edu­ca­tional program;

· Enrolled in or await­ing accep­tance from a Canadian-based post-educational insti­tu­tion for the Fall semes­ter of 2013; and

· A stu­dent who demon­strates aca­d­e­mic aspi­ra­tion and strives to sus­tain an opti­mal level of well­ness in spite of their IBD, allow­ing them to excel to reach their per­sonal and aca­d­e­mic goals and inspir­ing oth­ers to do the same. Visit<> for full appli­ca­tion details.


About CCFC:


· The Crohn’s and Col­i­tis Foun­da­tion of Canada (CCFC) is a volunteer-based reg­is­tered char­ity ded­i­cated to find­ing the cure for Crohn’s dis­ease and ulcer­a­tive col­i­tis and improv­ing the lives of chil­dren and adults affected by these chronic dis­eases. To date, the CCFC has invested more than $76 mil­lion in research, mak­ing the foun­da­tion a world leader in non-governmental fund­ing of IBD research.

· Cana­dian researchers funded by CCFC are con­duct­ing cut­ting edge research and are sus­tain­ing the hope for a cure worldwide.


Click here for more infor­ma­tion about CCFC!


About Abb­Vie Abb­Vie (NYSE:ABBV) is a global, research-based bio­phar­ma­ceu­ti­cal com­pany formed in 2013 fol­low­ing sep­a­ra­tion from Abbott. Abb­Vie com­bines the focus and pas­sion of a leading-edge biotech with the exper­tise and struc­ture of a long-established phar­ma­ceu­ti­cal leader. The company’s mis­sion is to use its exper­tise, ded­i­cated peo­ple and unique approach to inno­va­tion to develop and mar­ket advanced ther­a­pies that address some of the world’s most com­plex and seri­ous dis­eases. Abb­Vie aims to help patients live health­ier lives and col­lab­o­rate on sus­tain­able health­care solu­tions. Abb­Vie employs approx­i­mately 21,000 peo­ple world­wide and mar­kets med­i­cines in more than 170 coun­tries. For fur­ther infor­ma­tion on the com­pany and its peo­ple, port­fo­lio and com­mit­ments, please visit<> or<>. Fol­low @abb­vie on Twit­ter or check out careers on their Face­book page.







Tags: , , , , , , , , , , ,
Posted in CoolCanucks Reviews | 1 Comment »